Skip to main content
. 2017 Jul 19;2017:1401452. doi: 10.1155/2017/1401452

Table 1.

Characteristics of the three study groups.

All (n = 1559) RASIG (n = 794) GO (n = 493) SGO (n = 272) P
Age (years) 64.3 ± 5.4 64.5 ± 5.8 64.3 ± 4.9 63.9 ± 4.7 0.230
55–59 years (n, (%)) 345 (22.1) 193 (24.3) 94 (19.1) 58 (21.3) <0.001
60–64 years (n, (%)) 448 (28.7) 210 (26.4) 149 (30.2) 89 (32.7)
65–69 years (n, (%)) 465 (29.8) 204 (25.7) 166 (33.7) 95 (34.9)
70–75 years (n, (%)) 301 (19.3) 187 (23.6) 84 (17.0) 30 (11.0)
Gender, male (n, (%)) 743 (47.7) 386 (48.6) 213 (43.2) 144 (52.9) 0.027
Smoker, current (n, (%)) 231 (14.8) 142 (17.9) 63 (12.6) 27 (9.9) 0.001
BMI (kg/m2) 27.3 ± 4.5 27.6 ± 4.7 26.6 ± 4.4 27.3 ± 4.2 0.692
<25 (n, (%)) 516 (33.1) 249 (31.4) 188 (38.1) 79 (29.0) 0.036
25 to <30 (n, (%)) 673 (43.2) 343 (43.3) 199 (40.4) 131 (48.2)
≥30 (n, (%)) 369 (23.7) 201 (25.3) 106 (21.5) 62 (22.8)
Country
Belgium (n, (%)) 472 (30.3) 155 (19.5) 190 (38.5) 127 (46.7) <0.001
Finland (n, (%)) 253 (16.2) 69 (8.7) 132 (26.8) 52 (19.1)
Greece (n, (%)) 209 (13.4) 187 (23.6) 18 (3.7) 4 (1.5)
Italy (n, (%)) 323 (20.7) 187 (23.6) 87 (17.6) 49 (18.0)
Poland (n, (%)) 302 (19.4) 196 (24.7) 66 (13.4) 40 (14.7)

Values are means ± SD; P value: one-way ANOVA (continuous variables) and Pearson's chi-squared test (prevalence).